Sanofi-Aventis is a pharmaceutical company. They are the manufacturers of Insulin glargine (brand name "Lantus"), a long-acting insulin analog and Insulin glulisine (brand name "Apidra"). Sanofi-Aventis cover seven major therapeutic areas: cardiovascular, thrombosis, oncology, diabetes, central nervous system, internal medicine and vaccines. The company engages in the research, development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but they also develop over-the-counter medication.